Activating the Immune System to Treat Multiple Myeloma
This article was funded and directed by Bristol-Myers Squibb.
December 11, 2017|Hematology and Oncology
Sagar Lonial, MD
Chief Medical Officer, Winship Cancer Institute of Emory University
,Chair, Dept. of Hematology and Medical Oncology, Emory School of Medicine
Faculty/Faculty Disclosure
Dr. Lonial reports that he is a compensated consultant for Bristol-Myers Squibb; Celgene Corporation; Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; Millennium Pharmaceuticals, Inc.; Novartis Pharmaceuticals Corporation; and Onyx Pharmaceuticals, Inc.